Biodegradable human serum albumin nanoparticles as contrast agents for the detection of hepatocellular carcinoma by magnetic resonance imaging

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 87, Issue 1, 2014, Pages 132-141

  Watcharin, Waralee ^a   Schmithals, Christian ^b   Pleli, Thomas ^b   Köberle, Verena ^b   Korkusuz, Hüdayi ^b   Huebner, Frank ^b   Zeuzem, Stefan ^a   Korf, Hans W ^b   Vogl, Thomas J ^b   Rittmeyer, Claudia ^a   Terfort, Andreas ^a   Piiper, Albrecht ^a   Gelperina, Svetlana ^c   Kreuter, Jörg ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c Nanosystem LTD   (Russian Federation)

Author keywords

Gd DTPA; Human hepatocellular carcinoma (HCC); Human serum albumin; Magnetic resonance imaging (MRI); Nanoparticles; Rhodamine 123

Indexed keywords

CYANAMIDE; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; HUMAN SERUM ALBUMIN; NANOPARTICLE; PENTETIC ACID; RHODAMINE 123; ALBUMIN-(GADOLINIUM-DTPA); ALBUMINOID; BIOMATERIAL; CONTRAST MEDIUM; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTRAST; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INJECTION; LIVER CELL CARCINOMA; MOLECULAR STABILITY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PARTICLE SIZE; SERUM; ZETA POTENTIAL; ANIMAL; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; CHEMISTRY; DIAGNOSTIC USE; DRUG EFFECTS; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SURFACE PROPERTY; TRANSGENIC MOUSE; TUMOR CELL LINE;

ALBUMINS; ANIMALS; BIOCOMPATIBLE MATERIALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MAGNETIC RESONANCE IMAGING; MICE; MICE, TRANSGENIC; NANOPARTICLES; PARTICLE SIZE; SERUM ALBUMIN; SURFACE PROPERTIES;

EID: 84901594359     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2013.12.010     Document Type: Article

References (51)

1. G. Ratzinger, P. Agrawal, W. Korner, J. Lonkai, H. Sanders, E. Terreno, M. Wirth, G.J. Strijkers, K. Nicolay, and F. Gabor Surface modification of PLGA nanospheres with Gd-DTPA and Gd-DOTA for high-relaxivity MRI contrast agents Biomaterials 31 33 2010 8716 8723
2. C. Geraldes, and S. Laurent Classification and basic properties of contrast agents for magnetic resonance imaging Contrast Media Mol. Imag. 4 1 2009 1 23
3. I. Paschkunova-Martic, C. Kremser, K. Mistlberger, N. Shcherbakova, H. Dietrich, H. Talasz, Y.P. Zou, B. Hugl, M. Galanski, E. Solder, K. Pfaller, I. Holiner, W. Buchberger, B. Keppler, and P. Debbage Design, synthesis, physical and chemical characterisation, and biological interactions of lectin-targeted latex nanoparticles bearing Gd-DTPA chelates: an exploration of magnetic resonance molecular imaging (MRMI) Histochem. Cell Biol. 123 3 2005 283 301 (Pubitemid 40674679)
4. W.J.M. Mulder, G.J. Strijkers, G.A.F. van Tilborg, A.W. Griffioen, and K. Nicolay Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging NMR Biomed. 19 1 2006 142 164 (Pubitemid 43250800)
5. Y.J. Liu, Z.J. Chen, C.X. Liu, D.X. Yu, Z.J. Lu, and N. Zhang Gadolinium-loaded polymeric nanoparticles modified with anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer Biomaterials 32 22 2011 5167 5176
6. A. Zensi, D. Begley, C. Pontikis, C. Legros, L. Mihoreanu, S. Wagner, C. Buechel, H. von Briesen, and J. Kreuter Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones J. Control. Release 137 1 2009 78 86
7. J. Kreuter, T. Hekmatara, S. Dreis, T. Vogel, S. Gelperina, and K. Langer Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain J. Control. Release 118 1 2007 54 58 (Pubitemid 46283106)
8. K. Michaelis, M.M. Hoffmann, S. Dreis, E. Herbert, R.N. Alyautdin, M. Michaelis, J. Kreuter, and K. Langer Covalent linkage of apolipoprotein E to albumin nanoparticles strongly enhances drug transport into the brain J. Pharmacol. Exp. Ther. 317 3 2006 1246 1253 (Pubitemid 43764130)
9. H. Korkusuz, K. Ulbrich, K. Welzel, V. Koeberle, W. Watcharin, U. Bahr, V. Chernikov, T. Knobloch, S. Petersen, F. Huebner, H. Ackermann, S. Gelperina, W. Kromen, R. Hammerstingl, J. Haupenthal, F. Gruenwald, J. Fiehler, S. Zeuzem, J. Kreuter, T.J. Vogl, and A. Piiper Transferrin-coated gadolinium nanoparticles as MRI contrast agent Mol. Imag. Biol. 15 2 2013 148 154
10. K. Ulbrich, T. Hekmatara, E. Herbert, and J. Kreuter Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB) Eur. J. Pharm. Biopharm. 71 2 2009 251 256
11. Z. Chen, D. Yu, C. Liu, X. Yang, N. Zhang, C. Ma, J. Song, and Z. Lu Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent J. Drug Target. 19 8 2011 657 665
12. E. Nakamura, K. Makino, T. Okano, T. Yamamoto, and M. Yokoyama A polymeric micelle MRI contrast agent with changeable relaxivity J. Control. Release 114 3 2006 325 333 (Pubitemid 44376546)
13. H.E. Daldrup-Link, D. Golovko, B. Ruffell, D.G. DeNardo, R. Castaneda, C. Ansari, J.H. Rao, G.A. Tikhomirov, M.F. Wendland, C. Corot, and L.M. Coussens MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles Clin. Cancer Res. 17 17 2011 5695 5704
14. S.A. Molokhia, E.-K. Jeong, W.I. Higuchi, and S.K. Li Transscleral iontophoretic and intravitreal delivery of a macromolecule: study of ocular distribution in vivo and postmortem with MRI Exp. Eye Res. 88 3 2009 418 425
15. J. Haupenthal, V. Bihrer, H. Korkusuz, O. Kollmar, C. Schmithals, S. Kriener, K. Engels, T. Pleli, A. Benz, M. Canamero, T. Longerich, B. Kronenberger, S. Richter, O. Waidmann, T.J. Vogl, S. Zeuzem, and A. Piiper Reduced efficacy of the Plk1 inhibitor BI 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels Neoplasia 14 5 2012 410 419
16. C. Weber, C. Coester, J. Kreuter, and K. Langer Desolvation process and surface characterisation of protein nanoparticles Int. J. Pharm. 194 1 2000 91 102
17. C. Weber, J. Kreuter, and K. Langer Desolvation process and surface characteristics of HSA-nanoparticles Int. J. Pharm. 196 2 2000 197 200 (Pubitemid 30105742)
18. K. Langer, M.G. Anhorn, I. Steinhauser, S. Dreis, D. Celebi, I. Schrickel, S. Faust, and V. Vogel Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation Int. J. Pharm. 347 1-2 2008 109 117 (Pubitemid 350180317)
19. K. Langer, S. Balthasar, V. Vogel, N. Dinauer, H. von Briesen, and D. Schubert Optimization of the preparation process for human serum albumin (HSA) nanoparticles Int. J. Pharm. 257 1-2 2003 169 180 (Pubitemid 36507043)
20. J.M. Wild, J. Woodrow, E.J.R. van Beek, B. Misselwitz, and R. Johnson Evaluation of rHA labeled with Gd-DTPA for blood pool imaging and targeted contrast delivery Contrast Media Mol. Imag. 5 1 2010 39 43
21. T.N. Nagaraja, R.L. Croxen, S. Panda, R.A. Knight, K.A. Keenan, S.L. Brown, J.D. Fenstermacher, and J.R. Ewing Application of arsenazo III in the preparation and characterization of an albumin-linked, gadolinium-based macromolecular magnetic resonance contrast agent J. Neurosci. Methods 157 2 2006 238 245 (Pubitemid 44331976)
22. L. Telgmann, M. Holtkamp, J. Kuennemeyer, C. Gelhard, M. Hartmann, A. Klose, M. Sperling, and U. Karst Simple and rapid quantification of gadolinium in urine and blood plasma samples by means of total reflection X-ray fluorescence (TXRF) Metallomics 3 10 2011 1035 1040
23. R. Delfino, M. Altissimo, R.H. Menk, R. Alberti, T. Klatka, T. Frizzi, A. Longoni, M. Salome, G. Tromba, F. Arfelli, M. Clai, L. Vaccari, V. Lorusso, C. Tiribelli, and L. Pascolo X-ray fluorescence elemental mapping and microscopy to follow hepatic disposition of a Gd-based magnetic resonance imaging contrast agent Clin. Exp. Pharmacol. Physiol. 38 12 2011 834 845
24. K. Ulbrich, M. Michaelis, F. Rothweiler, T. Knobloch, P. Sithisarn, J. Cinatl, and J. Kreuter Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells Int. J. Pharm. 406 1-2 2011 128 134
25. F. Sarti, A. Staaf, D. Sakloetsakun, and A. Bernkop-Schnuerch Thiolated hydroxyethylcellulose: synthesis and in vitro evaluation Eur. J. Pharm. Biopharm. 76 3 2010 421 427
26. H. Korkusuz, K. Ulbrich, V. Bihrer, K. Welzel, V. Chernikov, T. Knobloch, S. Petersen, F. Huebner, H. Ackermann, S. Gelperina, Y. Korkusuz, W. Kromen, R. Hammerstingl, J. Haupenthal, J. Fiehler, S. Zeuzem, J. Kreuter, T.J. Vogl, and A. Piiper Contrast enhancement of the brain by folate-conjugated gadolinium-diethylenetriaminepentaacetic acid-human serum albumin nanoparticles by magnetic resonance imaging Mol. Imag. 11 4 2012 272 279
27. K. Ulbrich, T. Knobloch, and J. Kreuter Targeting the insulin receptor: nanoparticles for drug delivery across the blood-brain barrier (BBB) J. Drug Target. 19 2 2011 125 132
28. H. Amthor, T. Egelhof, I. McKinnell, M.E. Ladd, I. Janssen, J. Weber, H. Sinn, H.H. Schrenk, M. Forsting, T. Voit, and V. Straub Albumin targeting of damaged muscle fibres in the mdx mouse can be monitored by MRI Neuromuscul. Disord. 14 12 2004 791 796 (Pubitemid 39572399)
29. G. Tyler ICP-OES, ICP-MS and AAS techniques compared Spectrosc. Eur. 5 1995 14 22
30. O.G. Koch, P.D. Lafleur, and G.H. Morrison General-aspects of trace analytical methods - 5. Comparison of the abilities of trace analytical methods to determine small amounts or concentrations of elements Pure Appl. Chem. 54 8 1982 1565 1577
31. 3+-loaded polyamidoamine and hyperbranched dendrimers J. Biol. Inorg. Chem. 12 3 2007 406 420 (Pubitemid 46569283)
32. S. Essa, J.M. Rabanel, and P. Hildgen Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density Int. J. Pharm. 411 1-2 2011 178 187
33. H. Ersoy, and F.J. Rybicki Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis J. Magn. Reson. Imag. 26 5 2007 1190 1197 (Pubitemid 350058285)
34. E. Ledneva, S. Karie, V. Launay-Vacher, N. Janus, and G. Deray Renal safety of gadolinium-based contrast media in patients with chronic renal insufficiency Radiology 250 3 2009 618 628
35. J.K. Jiang, G. Oberdorster, and P. Biswas Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies J. Nanopart. Res. 11 1 2009 77 89
36. S.W. Bian, I.A. Mudunkotuwa, T. Rupasinghe, and V.H. Grassian Aggregation and dissolution of 4 nm ZnO nanoparticles in aqueous environments: influence of pH, ionic strength, size, and adsorption of humic acid Langmuir 27 10 2011 6059 6068
37. 2 nanoparticles J. Appl. Phys. 109 2 2011 5
38. G. Lehne, P. DeAngelis, O.P.F. Clausen, and H.E. Rugstad Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines Br. J. Cancer 74 11 1996 1719 1729 (Pubitemid 26401890)
39. X. Xu, R. Li, M. Ma, X. Wang, Y. Wang, and H. Zou Multidrug resistance protein P-glycoprotein does not recognize nanoparticle C-60: experiment and modeling Soft Matter 8 10 2012 2915 2923
40. J. Zastre, J. Jackson, M. Bajwa, R. Liggins, F. Iqbal, and H. Burt Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by caco-2 cells using low molecular weight methoxypolyethylene glycol-block- polycaprolactone diblock copolymers Eur. J. Pharm. Biopharm. 54 3 2002 299 309 (Pubitemid 35341830)
41. I.W. Bauer, S.-P. Li, Y.-C. Han, L. Yuan, and M.-Z. Yin Internalization of hydroxyapatite nanoparticles in liver cancer cells J. Mater. Sci. - Mater. Med. 19 3 2008 1091 1095 (Pubitemid 351337472)
42. P. Liu, Y. Sun, Q. Wang, Y. Sun, H. Li, and Y. Duan Intracellular trafficking and cellular uptake mechanism of mPEG-PLGA-PLL and mPEG-PLGA-PLL-Gal nanoparticles for targeted delivery to hepatomas Biomaterials 35 2 2013 760 770
43. R. Senetta, G. Stella, E. Pozzi, N. Sturli, D. Massi, and P. Cassoni Caveolin-1 as a promoter of tumour spreading: when, how, where and why J. Cell Mol. Med. 17 3 2013 325 336
44. I. Pashkunova-Martic, C. Kremser, M. Galanski, P. Schluga, V. Arion, P. Debbage, W. Jaschke, and B. Keppler Lectin conjugates as biospecific contrast agents for MRI. Coupling of lycopersicon esculentum agglutinin to linear water-soluble DTPA-loaded oligomers Mol. Imag. Biol. 13 3 2011 432 442
45. C.-H. Huang, and A. Tsourkas Gd-based macromolecules and nanoparticles as magnetic resonance contrast agents for molecular imaging Curr. Top. Med. Chem. 13 4 2013 411 421
46. L. Vander Elst, S. Laurent, H.M. Bintoma, and R.N. Muller Albumin-bound MRI contrast agents: the dilemma of the rotational correlation time Magn. Reson. Mater. Phys. Biol. Med. 12 2-3 2001 135 140 (Pubitemid 32510132)
47. C. Glaus, R. Rossin, M.J. Welch, and G. Bao In vivo evaluation of Cu-64-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent Bioconjug. Chem. 21 4 2010 715 722
48. M.O. Oyewumi, R.A. Yokel, M. Jay, T. Coakley, and R.J. Mumper Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice J. Control. Release 95 3 2004 613 626 (Pubitemid 38340510)
49. T. Bui, J. Stevenson, J. Hoekman, S. Zhang, K. Maravilla, and R.J.Y. Ho Novel Gd nanoparticles enhance vascular contrast for high-resolution magnetic resonance imaging PLoS ONE 5 9 2010
50. T. Ke, Y. Feng, J. Guo, D.L. Parker, and Z.-R. Lu Biodegradable cystamine spacer facilitates the clearance of Gd(III) chelates in poly(glutamic acid) Gd-DO3A conjugates for contrast-enhanced MR imaging Magn. Reson. Imag. 24 7 2006 931 940 (Pubitemid 44205384)
51. J.V. Jokerst, T. Lobovkina, R.N. Zare, and S.S. Gambhir Nanoparticle PEGylation for imaging and therapy Nanomedicine 6 4 2011 715 728